Assimakopoulos Stelios F, Thomopoulos Konstantinos C
Department of Internal Medicine, University Hospital of Patras, Patras 26504, Greece.
Division of Gastroenterology, Department of Internal Medicine, University Hospital of Patras, Patras 26504, Greece.
Gastroenterology Res. 2009 Feb;2(1):1-7. doi: 10.4021/gr2008.12.1253. Epub 2009 Jan 20.
Acute upper gastrointestinal bleeding remains one of the most frequent and emergent conditions in everyday clinical practice and a challenge for doctors. Peptic ulcer is responsible for more than half of acute upper gastrointestinal bleeding and is the most frequent cause of serious non-variceal bleeding. Despite progress in diagnosis and management in these patients, the recurrence of bleeding remains an important problem. Several drugs and endoscopic techniques, alone or in combination, have been evaluated in many studies and there is presently enough experience in terms of their efficacy. Endoscopic hemostasis is more effective than any other therapeutic intervention in the treatment of patients with non-variceal upper gastrointestinal bleeding. In patients with high risk of rebleeding spots, the combination of endoscopic hemostasis with high dose proton pump inhibitors is the most effective strategy to reduce bleeding recurrences and the need for surgery.
急性上消化道出血仍然是日常临床实践中最常见且紧急的病症之一,也是医生面临的一项挑战。消化性溃疡导致的急性上消化道出血占比超过一半,是严重非静脉曲张性出血最常见的原因。尽管在这些患者的诊断和治疗方面取得了进展,但出血复发仍然是一个重要问题。在许多研究中,已对多种单独或联合使用的药物及内镜技术进行了评估,目前在其疗效方面已有足够的经验。内镜止血在治疗非静脉曲张性上消化道出血患者方面比任何其他治疗干预措施都更有效。在再出血风险高的患者中,内镜止血与高剂量质子泵抑制剂联合使用是减少出血复发和手术需求的最有效策略。